First Internet Bancorp Authorizes Stock Repurchase Program
FISHERS, Ind.–(BUSINESS WIRE)–The Board of Directors of First Internet Bancorp (the “Company”) (Nasdaq: INBK) has…
FISHERS, Ind.–(BUSINESS WIRE)–The Board of Directors of First Internet Bancorp (the “Company”) (Nasdaq: INBK) has…
JERUSALEM, Dec. 20, 2022 (GLOBE NEWSWIRE) — via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV)(“Company”),…
Benetic® crosses $10b in proposals and benchmarks JACKSON, Wyo., Dec. 20, 2022 (GLOBE NEWSWIRE) —…
PALO ALTO, Calif.–(BUSINESS WIRE)–#AI—SambaNova Systems, the company delivering the industry’s only comprehensive software, hardware, and…
FOLSOM, Calif.–(BUSINESS WIRE)–PowerSchool Holdings, Inc. (NYSE: PWSC) (“PowerSchool” or the “Company”), the leading provider of…
This year’s awards recognize Enterprise Technology leaders across 11 categories NEWTON, Mass.–(BUSINESS WIRE)–TechTarget, Inc. (Nasdaq:…
Industry CLM veteran joins Pactum AI as Vice President of Sales MENLO PARK, Calif. &…
Emburse is positioned in the Leaders category for small business, mid-market, and enterprise expense automation…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to five classes of mortgage pass-through certificates from BINOM…
SAN FRANCISCO, Dec. 20, 2022 (GLOBE NEWSWIRE) — It’s a wrap — Almost! Here’s 2022…
Extensive catalog service provides real-time, ready to deploy integrations with complete visibility and control of…
The online community will teach students from all walks of life Milan, Italy–(Newsfile Corp. –…
Toronto, Ontario–(Newsfile Corp. – December 20, 2022) – BELGRAVIA HARTFORD CAPITAL INC. (CSE: BLGV) (“Belgravia…
More than 2,665 new miners started hashing at the Wolf Hollow site Production capacity jumps…
MANITOBA, CANADA, Dec 21, 2022 – (ACN Newswire) – Snow Lake Resources Ltd., d/b/a Snow…
Financial institutions of all sizes can offer consumers a debit card that optimizes cash flow…
New Leadership Brings a Wealth of Executive Experience Guiding Hyperscale Growth and Financial Success Dallas,…
– Cohort 4 Dosing Stopped per Clinical Trial Protocol due to Dose-Limiting Toxicities – –…
FDA granted IND clearance for IVS-3001, Invectys’s lead engineered anti-HLA–G CAR-T cell therapy, for the…
Phase 3, registrational studies remain on track for first half of 2023 topline data readout…